Synthetic alcohol: Booze with all the buzz — but without the hangover?

The synthetic alcohol's basis is gamma-aminobutyric acid, an amino acid that targets receptors in the front of the brain that trigger the relaxation and sociability alcohol brings, while avoiding the chaos it wreaks on the body. Credit: Matt Biddulph via CC-BY-SA-2.0
The synthetic alcohol's basis is gamma-aminobutyric acid, an amino acid that targets receptors in the front of the brain that trigger the relaxation and sociability alcohol brings, while avoiding the chaos it wreaks on the body. Credit: Matt Biddulph via CC-BY-SA-2.0

What if you could indulge in your favorite cocktails with no hangover or other ill effects?

That’s one of the goals for researchers working to make one of the world’s oldest vices less harmful. Some are developing hormone shots to help people sober up quickly. Others are working on alcohol substitutes that target receptors in the brain that affect happiness, while dodging those that make imbibers slur and weave.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

GABA receptors are the first contact for alcohol in the brain, opening up and relaxing people, [neuropsychopharmacologist David] Nutt says. But alcohol then also floods the brain with other neurotransmitters that can cause nasty aftereffects.

Creating a substance that targets only the GABA receptors allows the brain to then turn on dopamine and serotonin naturally as the pleasures of the evening take off, he says. “It feels like what a glass of wine feels like. It feels relaxing. It makes you a bit more chatty, a bit more socially engaged with people,” he says of the product GABA Labs is developing, dubbed Alcarelle.

….

The company is working to raise about £8 million (around $10.3 million), with an aim to complete food-safety testing in the U.S. by mid-2026, where it will launch ahead of European and U.K. markets.

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Wave Crest Over Red Cross
Viewpoint: Here are the election-inspired Trump administration healthcare policy reversals expected in the coming months
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Democratic Donkey Plowing at Sunset
Viewpoint: Democratic tsunami: As the red tide recedes, here are the most likely shifts in food and agricultural policy
p22_spraying_2
How climate change is driving increased pesticide usage
Aerial Sprayer Over Gradient Fields
Farming, food, and chemicals: Post-midterms, the MAHA alliance between Democrats and MAGA Republicans is bruised but not cowed. What comes next?
Screenshot-2026-11-05-at-1.20.54-PM
$7.35 billion PFAS settlement: 3M to pay people who blame health problems on ‘forever chemicals’ phased out of firefighting foam for more than 20 years
Blue Checklist in Centered Hand
Viewpoint: From Medicaid cuts to MAHA-backed anti-vaccine and chemical hysteria, voters reject Republicans’ science-skeptical agenda
Crumbling MAHA Stage Portrait
Cataloging the RFK Jr.-MAHA crushing midterm collapse
Bayer Crop Circle in Golden Wheat
Making fertilizer from thin air: Bayer’s gene-editing innovation could dramatically cut chemical fertilizer use in growing food
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.